Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loic Reppel

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid TumorsGiovanni Fucà, Loic Reppel, Elisa Landoni, et al.
Bio-Medical Materials and Engineering|July 13, 2012
Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansionTalar Margossian, Loic Reppel, Nehman Makdissy, et al.
Immunologic Research|October 12, 2017
Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15Yu Xiong, Manon Mouginot, Loic Reppel, et al.
Biotechnology Progress|July 30, 2019
Impact of the type of microcarrier and agitation modes on the expansion performances of mesenchymal stem cells derived from umbilical cordCéline Loubière, Caroline Sion, Natalia De Isla, et al.
Journal of Cellular and Molecular Medicine|January 28, 2022
Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantationCécile Pochon, Anne-Béatrice Notarantonio, Caroline Laroye, et al.
Current Stem Cell Research & Therapy|February 15, 2014
Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic contextLoic Reppel, Talar Margossian, Layale Yaghi, et al.
Stem Cells and Development|July 29, 2016
Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-GWen-Jing Du, Loic Reppel, Léonore Leger, et al.
Frontiers in Medicine|September 14, 2023
Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trialCécile Pochon, Caroline Laroye, Antoine Kimmoun, et al.
Bone Marrow Transplantation|December 11, 2025
Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest linkUgo Chartral, Jeanne Galaine, Camille Giverne, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid TumorsGiovanni Fucà, Loic Reppel, Elisa Landoni, et al.
Bio-Medical Materials and Engineering|July 13, 2012
Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansionTalar Margossian, Loic Reppel, Nehman Makdissy, et al.
Immunologic Research|October 12, 2017
Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15Yu Xiong, Manon Mouginot, Loic Reppel, et al.
Biotechnology Progress|July 30, 2019
Impact of the type of microcarrier and agitation modes on the expansion performances of mesenchymal stem cells derived from umbilical cordCéline Loubière, Caroline Sion, Natalia De Isla, et al.
Journal of Cellular and Molecular Medicine|January 28, 2022
Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantationCécile Pochon, Anne-Béatrice Notarantonio, Caroline Laroye, et al.
Current Stem Cell Research & Therapy|February 15, 2014
Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic contextLoic Reppel, Talar Margossian, Layale Yaghi, et al.
Stem Cells and Development|July 29, 2016
Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-GWen-Jing Du, Loic Reppel, Léonore Leger, et al.
Frontiers in Medicine|September 14, 2023
Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trialCécile Pochon, Caroline Laroye, Antoine Kimmoun, et al.
Bone Marrow Transplantation|December 11, 2025
Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest linkUgo Chartral, Jeanne Galaine, Camille Giverne, et al.
Pageof 1